639 related articles for article (PubMed ID: 30060815)
1. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
[TBL] [Abstract][Full Text] [Related]
2. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
3. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
4. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid metabolism in cancer signalling and therapy.
Ogretmen B
Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipid metabolism enzymes as targets for anticancer therapy.
Kok JW; Sietsma H
Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220
[TBL] [Abstract][Full Text] [Related]
7. Roles of bioactive sphingolipids in cancer biology and therapeutics.
Saddoughi SA; Song P; Ogretmen B
Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of sphingolipid metabolism in cancer.
Ryland LK; Fox TE; Liu X; Loughran TP; Kester M
Cancer Biol Ther; 2011 Jan; 11(2):138-49. PubMed ID: 21209555
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid targets in cancer therapy.
Modrak DE; Gold DV; Goldenberg DM
Mol Cancer Ther; 2006 Feb; 5(2):200-8. PubMed ID: 16505092
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
11. Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C; Norris JS; White-Gilbertson S
Adv Cancer Res; 2018; 140():265-293. PubMed ID: 30060812
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Ung J; Tan SF; Fox TE; Shaw JJP; Vass LR; Costa-Pinheiro P; Garrett-Bakelman FE; Keng MK; Sharma A; Claxton DF; Levine RL; Tallman MS; Cabot MC; Kester M; Feith DJ; Loughran TP
Blood Rev; 2022 Sep; 55():100950. PubMed ID: 35487785
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
14. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
Kim JL; Mestre B; Shin SH; Futerman AH
Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid-Transporting Proteins as Cancer Therapeutic Targets.
Samaha D; Hamdo HH; Wilde M; Prause K; Arenz C
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330821
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.
Camp ER; Patterson LD; Kester M; Voelkel-Johnson C
Cancer Biol Ther; 2017 Sep; 18(9):640-650. PubMed ID: 28686076
[TBL] [Abstract][Full Text] [Related]
17. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
Ozbayraktar FB; Ulgen KO
J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
[TBL] [Abstract][Full Text] [Related]
18. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
[TBL] [Abstract][Full Text] [Related]
19. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?
Radin NS
Eur J Biochem; 2001 Jan; 268(2):193-204. PubMed ID: 11168352
[TBL] [Abstract][Full Text] [Related]
20. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
Ekiz HA; Baran Y
Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
